19-Feb-2026
RBC Capital Remains a Buy on HCA Healthcare (HCA)
TipRanks (Wed, 18-Feb 8:45 PM ET)
Nasdaq, S&P 500 futures lower as Wall Street returns from holiday
Seeking Alpha News (Tue, 17-Feb 5:14 AM ET)
Notable healthcare headlines for the week: AstraZeneca, CVS Health, and Moderna in focus
Seeking Alpha News (Sun, 15-Feb 9:05 AM ET)
HCA Healthcare Hospitals Named on America's 50 Best Hospitals List for 2026 by Healthgrades
Business Wire (Thu, 29-Jan 8:30 AM ET)
HCA Healthcare Reports Fourth Quarter 2025 Results and Provides 2026 Guidance
Business Wire (Tue, 27-Jan 7:00 AM ET)
HCA Healthcare Names Erica Rossitto as Chief Nurse Executive
Business Wire (Thu, 15-Jan 8:30 AM ET)
HCA Healthcare, Inc. 4th Quarter 2025 Earnings Conference Call
Business Wire (Tue, 30-Dec 4:00 PM ET)
HCA Healthcare Names Virginia Tenpenny Vice President of Community Engagement
Business Wire (Tue, 9-Dec 8:30 AM ET)
HCA Healthcare Announces $4.8 Million Gift to Help Launch Pepperdine University's School of Nursing
Business Wire (Fri, 5-Dec 8:30 AM ET)
Market Chameleon (Fri, 24-Oct 7:47 AM ET)
HCA Healthcare is a Nashville-based healthcare provider organization operating the largest collection of acute-care hospitals in the United States. As of December 2025, the firm owned and operated 190 hospitals and over 2,500 outpatient facillities across 19 states and a small foothold in the United Kingdom
Hca Healthcare trades on the NYSE stock market under the symbol HCA.
As of February 19, 2026, HCA stock price declined to $528.66 with 774,044 million shares trading.
HCA has a beta of 0.24, meaning it tends to be less sensitive to market movements. HCA has a correlation of 0.02 to the broad based SPY ETF.
HCA has a market cap of $118.22 billion. This is considered a Large Cap stock.
Last quarter Hca Healthcare reported $20 billion in Revenue and $8.01 earnings per share. This fell short of revenue expectation by $-145 million and exceeded earnings estimates by $.59.
In the last 3 years, HCA traded as high as $552.90 and as low as $215.96.
The top ETF exchange traded funds that HCA belongs to (by Net Assets): VTI, VOO, IVV, SPY, VTV.
HCA has outperformed the market in the last year with a price return of +67.8% while the SPY ETF gained +13.1%. HCA has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +10.7% and +7.1%, respectively, while the SPY returned +4.0% and -0.2%, respectively.
HCA support price is $524.59 and resistance is $545.45 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that HCA shares will trade within this expected range on the day.